Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy

Neurotherapeutics

Volumn 8, Issue 3, 2011, Pages 319-329

  Ovbiagele, Bruce ^a   Nguyen Huynh, Mai N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; Incidence; Mortality; Outcome; Review; Stroke

Indexed keywords

ALCOHOL CONSUMPTION; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DEVELOPED COUNTRY; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; HEALTH CARE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HUMAN; IMMOBILIZATION; INCIDENCE; INFECTION; INFLAMMATION; KIDNEY DISEASE; LIFESTYLE MODIFICATION; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL STATUS; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

AGE FACTORS; ALCOHOL DRINKING; EPIDEMIOLOGIC STUDIES; ETHNIC GROUPS; HUMANS; INCIDENCE; LIFE STYLE; PREVALENCE; RISK FACTORS; SEX FACTORS; SOCIAL CLASS; STROKE;

EID: 79960798567     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-011-0053-1     Document Type: Review

References (87)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the american heart association. Circulation 2011; 123: e18-e209.
2. Chen C, Hsu C. Stroke: an overview. In: Lisak R, Truong, DD, Caroll, WM, Bhidayasiri R (eds) International neurology: a clinical approach. West Sussex, United Kingdom: Wiley-Blackwell, 2009: 1.
3. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003; 34: 2060-2065.
4. Chong J, Sacco R. Risk factors for stroke, assessing risk, and the mass and high-risk approaches for stroke prevention. In: Gorelick PB, ed. Continuum: Stroke Prevention. Hagerstwon, Maryland: Lippincott Williams and Wilkins, 2005: 18-34.
5. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998; 91: 288-294.
6. Ovbiagele B. National sex-specific trends in hospital-based stroke rates. J Stroke Cerebrovasc Dis 2010. doi: 10. 1016/j. jstrokecerebrovasdis. 2010. 03. 007.
7. Johnston SC, Fayad P, Gorelick PB, et al. Prevalence and knowledge of transient ischemic attacks among us adults. Neurology 2003; 60: 1429-1434.
8. Brown RD Jr, Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP. Incidence of transient ischemic attack in rochester, minnesota, 1985-1989. Stroke 1998; 29: 2109-2113.
9. Feigin VL, Shishkin SV, Tzirkin GM, et al. A population-based study of transient ischemic attack incidence in Novosibirsk, Russia, 1987-1988 and 1996-1997. Stroke 2000; 31: 9-13.
10. Zupping R, Roose M. Epidemiology of cerebrovascular disease in Tartu, Estonia, USSR, 1970 through 1973. Stroke 1976; 7: 187-190.
11. Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke 1989; 20: 333-339.
12. Giroud M, Milan C, Beuriat P, et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The stroke registry of dijon: 1985-1989. Int J Epidemiol 1991; 20: 892-899.
13. Mettinger KL, Soderstrom CE, Allander E. Epidemiology of acute cerebrovascular disease before the age of 55 in the stockholm county 1973-77: I. Incidence and mortality rates. Stroke 1984; 15: 795-801.
14. Ueda K, Kiyohara Y, Hasuo Y, et al. Transient cerebral ischemic attacks in a Japanese community, Hisayama, Japan. Stroke 1987; 18: 844-848.
15. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276-2293.
16. Ovbiagele B, Kidwcell CS, Saver JL. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke 2003; 34: 919-924.
17. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6: 1063-1072.
18. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369: 283-292.
19. Wolf P, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke 1991; 22: 312-318.
20. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (The Interstroke Study): a case-control study. Lancet 2010; 376: 112-123.
21. Elkind MS. Inflammatory mechanisms of stroke. Stroke 2010; 41: S3-S8.
22. Lee M, Ovbiagele B. Reno-cerebrovascular disease: linking the nephron and neuron. Expert Rev Neurother 2011; 11: 241-249.
23. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
24. Chobanian A, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
25. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
26. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
27. Tayal AH, Tian M, Kelly KM, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology 2008; 71: 1696-1701.
28. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-257.
29. Folsom AR, Rasmussen ML, Chambless LE, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The atherosclerosis risk in communities (aric) study investigators. Diabetes Care 1999; 22: 1077-1083.
30. Rundek T, Gardener H, Xu Q, et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern manhattan study. Arch Neurol 2010; 67: 1195-1200.
31. Boden-Albala B, Sacco RL, Lee HS, et al. Metabolic syndrome and ischemic stroke risk: Northern manhattan study. Stroke 2008; 39: 30-35.
32. Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006; 66: 1344-1349.
33. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517-584.
34. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004; 63: 1868-1875.
35. Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke 1991; 22: 1485-1490.
36. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009; 40: e573-e583.
37. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 2010; 41: e11-e17.
38. MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: The stroke prevention in young women study. Stroke 2007; 38: 2438-2445.
39. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
40. National Center for Health Statistics. Vital Statistics of the United States, data warehouse. http://www. cdc. gov/nchs/data/dvs/MortFinal2003_WorkTable307. pdf.
41. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black, and hispanic residents of an urban community: The Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147: 259-268.
42. Lackland DT, Bachman DL, Carter TD, Barker DL, Timms S, Kohli H. The geographic variation in stroke incidence in two areas of the southeastern stroke belt: The Anderson and Pee Dee Stroke Study. Stroke 1998; 29: 2061-2068.
43. El-Saed A, Kuller LH, Newman AB, et al. Geographic variations in stroke incidence and mortality among older populations in four us communities. Stroke 2006; 37: 1975-1979.
44. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003; 74: 317-321.
45. Rosamond WD, Folsom AR, Chambless LE, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the atherosclerosis risk in communities (aric) cohort. Stroke 1999; 30: 736-743.
46. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics--2007 update: A report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2007; 115: e69-171.
47. Nakayama H, Jorgensen HS, Raaschou HO, Olsen TS. The influence of age on stroke outcome. The Copenhagen Stroke Study. Stroke 1994; 25: 808-813.
48. Di Carlo A, Lamassa M, Pracucci G, et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: A European perspective. European Biomed Study of Stroke Care Group. Stroke 1999; 30: 2313-2319.
49. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40: 1082-1090.
50. Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth L. Sex differences in the use of intravenous RT-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke 2009; 40: 1743-1749.
51. Di Carlo A, Lamassa M, Baldereschi M, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: aata from a multicenter multinational hospital-based registry. Stroke 2003; 34: 1114-1119.
52. Kapral MK, Fang J, Hill MD, et al. Sex differences in stroke care and outcomes: Results from the registry of the Canadian Stroke Network. Stroke 2005; 36: 809-814.
53. Glader EL, Stegmayr B, Norrving B, et al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke 2003; 34: 1970-1975.
54. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke 2000; 31: 1833-1837.
55. Silva GS, Lima FO, Camargo EC, et al. Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis 2010; 30: 470-475.
56. Gargano JW, Reeves MJ. Sex differences in stroke recovery and stroke-specific quality of life: Results from a statewide stroke registry. Stroke 2007; 38: 2541-2548.
57. Allen NB, Holford TR, Bracken MB, et al. Trends in one-year recurrent ischemic stroke among the elderly in the USA: 1994-2002. Cerebrovasc Dis 2010; 30: 525-532.
58. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009; 8: 345-354.
59. Howard G, Cushman M, Prineas RJ, et al. Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. Prev Med 2009; 49: 129-132.
60. Steenland K, Hu S, Walker J. All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997. Am J Public Health 2004; 94: 1037-1042.
61. Fukuda Y, Nakamura K, Takano T. Cause-specific mortality differences across socioeconomic position of municipalities in Japan, 1973-1977 and 1993-1998: Increased importance of injury and suicide in inequality for ages under 75. Int J Epidemiol 2005; 34: 100-109.
62. Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke 2002; 33: 268-273.
63. Putman K, De Wit L, Schoonacker M, et al. Effect of socioeconomic status on functional and motor recovery after stroke: A European Multicentre Study. J Neurol Neurosurg Psychiatry 2007; 78: 593-599.
64. Li C, Hedblad B, Rosvall M, Buchwald F, Khan FA, Engstrom G. Stroke incidence, recurrence, and case-fatality in relation to socioeconomic position: a population-based study of middle-aged Swedish men and women. Stroke 2008; 39: 2191-2196.
65. Lofmark U, Hammarstrom A. Education-related differences in case fatality among elderly with stroke. Neuroepidemiology 2008; 31: 21-27.
66. Ayala C, Greenlund KJ, Croft JB, et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995-1998. Am J Epidemiol 2001; 154: 1057-1063.
67. Lisabeth LD, Smith MA, Brown DL, Moye LA, Risser JM, Morgenstern LB. Ethnic differences in stroke recurrence. Ann Neurol 2006; 60: 469-475.
68. Uchino K, Risser JM, Smith MA, Moye LA, Morgenstern LB. Ischemic stroke subtypes among Mexican Americans and non-Hispanic whites: the BASIC project. Neurology 2004; 63: 574-576.
69. Qureshi AI, Feldmann E, Gomez CR, et al. Consensus conference on intracranial atherosclerotic disease: Rationale, methodology, and results. J Neuroimaging 2009; 19(suppl 1): 1S-10S.
70. Sacco RL, Hauser WA, Mohr JP, Foulkes MA. One-year outcome after cerebral infarction in whites, blacks, and hispanics. Stroke 1991; 22: 305-311.
71. Sacco RL, Boden-Albala B, Abel G, et al. Race-ethnic disparities in the impact of stroke risk factors: The Northern Manhattan Stroke Study. Stroke 2001; 32: 1725-1731.
72. Howard G, Prineas R, Moy C, et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the reasons for geographic and racial differences in stroke study. Stroke 2006; 37: 1171-1178.
73. Frey JL, Jahnke HK, Bulfinch EW. Differences in stroke between white, Hispanic, and Native American patients: The Barrow Neurological Institute Stroke Database. Stroke 1998; 29: 29-33.
74. Smith MA, Doliszny KM, Shahar E, McGovern PG, Arnett DK, Luepker RV. Delayed hospital arrival for acute stroke: The Minnesota Stroke Survey. Ann Intern Med 1998; 129: 190-196.
75. Goldstein LB, Edwards MG, Wood DP. Delay between stroke onset and emergency department evaluation. Neuroepidemiology 2001; 20: 196-200.
76. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Pre-hospital and emergency department delays after acute stroke: The Genentech Stroke Presentation Survey. Stroke 2000; 31: 2585-2590.
77. Zweifler RM, Lyden PD, Taft B, Kelly N, Rothrock JF. Impact of race and ethnicity on ischemic stroke. The University Of California At San Diego Stroke Data Bank. Stroke 1995; 26: 245-248.
78. Johnston SC, Fung LH, Gillum LA, et al. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 2001; 32: 1061-1068.
79. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001; 32: 1832-1840.
80. Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA stroke study: neurologist care is associated with increased testing but improved outcomes. Neurology 2003; 61: 792-796.
81. Cheng EM, Birbeck G, Vickrey B. VA stroke study: Neurologist care is associated with increased testing but improved outcomes. Neurology 2004; 62: 1914-1915.
82. Schwamm LH, Reeves MJ, Pan W, et al. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation 2010; 121: 1492-1501.
83. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355-369.
84. Yang Q, Botto LD, Erickson JD, et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006; 113: 1335-1343.
85. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (oxford vascular study). Lancet 2004; 363: 1925-1933.
86. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006; 296: 2939-2946.
87. Ovbiagele B. Nationwide trends in in-hospital mortality among patients with stroke. Stroke 2010; 41: 1748-1754.